Cerebral Aneurysm Management Market

Key Players

• Acadia Pharmaceuticals Inc
• F. Hoffmann-La Roche Ag
• Merck Sharp & Dohme Corp
• Novartis
• Orion Corporation
• The Vanguard Group
• Berkshire Hathaway
• UCB S.A